New Haven, CT, United States of America

Eric D Stern

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 48(Granted Patents)


Location History:

  • Cambridge, MA (US) (2015 - 2017)
  • New Haven, CT (US) (2015 - 2018)
  • Watertown, MA (US) (2018)
  • Jamaica Plain, MA (US) (2018 - 2022)
  • Charlestown, MA (US) (2021 - 2024)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: Innovations by Eric D. Stern: A Leader in Antimicrobial Testing and Drug Delivery Systems

Introduction

Eric D. Stern is a prominent inventor based in New Haven, CT, known for his significant contributions to the fields of antimicrobial susceptibility testing and drug delivery systems. With a remarkable record of 23 patents, Stern is at the forefront of innovative solutions that aim to enhance medical diagnostics and therapeutic efficacy.

Latest Patents

Among his notable inventions, Stern’s latest patents include groundbreaking advancements in antimicrobial susceptibility testing. His invention titled "Methods for improved rapid antimicrobial susceptibility testing" focuses on providing efficient and versatile analysis for clinical samples. This innovation aims to offer reliable results that can significantly impact patient care by improving the speed and accuracy of diagnostics.

Another noteworthy patent is the development of "Nanolipogel vehicles for controlled delivery of different pharmaceutical agents." This invention introduces a novel delivery vehicle consisting of a lipid layer encasing a hydrogel core. The unique structure allows for the incorporation and controlled release of various chemical entities, including proteins and small hydrophobic drugs. By utilizing nanolipogels, Stern's work ensures the sustained release of agents with varying molecular weights and compositions, ultimately enhancing biodistribution and therapeutic outcomes.

Career Highlights

Stern has contributed his expertise at esteemed institutions, including Selux Diagnostics, Inc. and Yale University. His work in these organizations has allowed him to leverage cutting-edge research to foster innovations in medical technology and improve patient treatment options.

Collaborations

Throughout his career, Stern has collaborated with notable professionals, including Kelly Flentie and Aleksandar Vacic. These partnerships have facilitated the sharing of knowledge and expertise, further driving advancements in their respective fields and fostering innovation in the healthcare landscape.

Conclusion

Eric D. Stern's ongoing commitment to innovation is evidenced by his extensive patent portfolio and collaborative endeavors. His work not only demonstrates advancements in antimicrobial susceptibility testing but also reflects the vast potential of drug delivery systems. As a leading inventor, Stern continues to pave the way for future breakthroughs in healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…